Show simple item record

dc.contributor.authorAshwood, KLen_US
dc.contributor.authorGillan, Nen_US
dc.contributor.authorHorder, Jen_US
dc.contributor.authorHayward, Hen_US
dc.contributor.authorWoodhouse, Een_US
dc.contributor.authorMcEwen, FSen_US
dc.contributor.authorFindon, Jen_US
dc.contributor.authorEklund, Hen_US
dc.contributor.authorSpain, Den_US
dc.contributor.authorWilson, CEen_US
dc.contributor.authorCadman, Ten_US
dc.contributor.authorYoung, Sen_US
dc.contributor.authorStoencheva, Ven_US
dc.contributor.authorMurphy, CMen_US
dc.contributor.authorRobertson, Den_US
dc.contributor.authorCharman, Ten_US
dc.contributor.authorBolton, Pen_US
dc.contributor.authorGlaser, Ken_US
dc.contributor.authorAsherson, Pen_US
dc.contributor.authorSimonoff, Een_US
dc.contributor.authorMurphy, DGen_US
dc.date.accessioned2016-10-19T14:31:30Z
dc.date.available2016-04-21en_US
dc.date.issued2016-09en_US
dc.date.submitted2016-10-11T10:06:05.622Z
dc.identifier.issn0033-2917en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/15945
dc.description.sponsorshipThis work was supported by a National Institute for Health Research (NIHR) programme grant (RP-PG-0606-1045), by the BGC as well as by the European Union via the EU-AIMS consortium. J.H. was supported by the Wellcome Trust and by the Biomedical Research Centre (BRC) at King's College London. D.G.M was supported by the Dr Mortimer D. Sackler Foundation. P.B was supported by an NIHR Senior Investigator award and the BRC in Mental Health at the South London and Maudsley NHS Trust. C.E.W receives postdoctoral research funding via the Marie Curie Action, co-financed by the Junta de Andalucía and the European Commission under Talentia Postdoc grant number 267 226. The authors acknowledge financial support from the Department of Health via the NIHR BRC and Dementia Unit awarded to South London and Maudsley NHS Foundation Trust, in partnership with King's College London and King's College Hospital NHS Foundation Trust. This work was supported by EU-AIMS (European Autism Interventions), which receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, the resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (grant FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contributions, and from Autism Speaks.en_US
dc.format.extent2595 - 2604en_US
dc.relation.ispartofPSYCHOLOGICAL MEDICINEen_US
dc.rightsThis is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creative commons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.subjectAutismen_US
dc.subjectautism spectrum disordersen_US
dc.subjectneurodevelopmental disordersen_US
dc.subjectscreeningen_US
dc.subjectself-reporten_US
dc.titlePredicting the diagnosis of autism in adults using the Autism-Spectrum Quotient (AQ) questionnaireen_US
dc.typeArticle
dc.rights.holder© Cambridge University Press 2016
dc.identifier.doi10.1017/S0033291716001082en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382567600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue12en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume46en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record